National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 2 of 2 Research Studies DisplayedTilson H, Hines LE, McEvoy G
AHRQ Author: Helwig AL
Recommendations for selecting drug-drug interactions for clinical decision support.
A work group consisting of 20 experts in pharmacology, drug information, and clinical decision support (CDS) from academia, government agencies, health information vendors, and healthcare organizations was convened. It recommended a transparent, systematic, and evidence-driven process with graded recommendations by a consensus panel of experts and oversight by a national organization.
AHRQ-authored.
Citation: Tilson H, Hines LE, McEvoy G .
Recommendations for selecting drug-drug interactions for clinical decision support.
Am J Health Syst Pharm 2016 Apr 15;73(8):576-85. doi: 10.2146/ajhp150565.
.
.
Keywords: Clinical Decision Support (CDS), Adverse Drug Events (ADE), Medication: Safety, Medication, Health Information Technology (HIT)
Topaz M, Lai K, Dhopeshwarkar N
Clinicians' reports in electronic health records versus patients' concerns in social media: A pilot study of adverse drug reactions of aspirin and atorvastatin.
The study’s objective was to compare electronic health record data and social media data to better understand differences and similarities between clinician-reported adverse drug reactions (ADRs) and patients' concerns regarding aspirin and atorvastatin. It found that the most frequently reported ADRs matched the most frequent patients' concerns. However, several less frequently reported reactions were more prevalent on social media (i.e., aspirin-induced hypoglycemia was discussed only on social media).
AHRQ-funded; HS022728.
Citation: Topaz M, Lai K, Dhopeshwarkar N .
Clinicians' reports in electronic health records versus patients' concerns in social media: A pilot study of adverse drug reactions of aspirin and atorvastatin.
Drug Saf 2016 Mar;39(3):241-50. doi: 10.1007/s40264-015-0381-x..
Keywords: Electronic Health Records (EHRs), Social Media, Health Information Technology (HIT), Adverse Drug Events (ADE), Patient Safety